Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,868 INR | +1.41% | +4.42% | -0.80% |
08:16am | Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity | MT |
Apr. 19 | Indian Equities Close Higher on Friday, Led by Metal, Banking Stocks | MT |
Sales 2024 * | 76.79B 921M | Sales 2025 * | 88.63B 1.06B | Capitalization | 1,012B 12.14B |
---|---|---|---|---|---|
Net income 2024 * | 15.42B 185M | Net income 2025 * | 20.4B 245M | EV / Sales 2024 * | 12.6 x |
Net cash position 2024 * | 45.73B 548M | Net cash position 2025 * | 47.78B 573M | EV / Sales 2025 * | 10.9 x |
P/E ratio 2024 * |
65.3
x | P/E ratio 2025 * |
49.5
x | Employees | 8,433 |
Yield 2024 * |
0.65% | Yield 2025 * |
0.74% | Free-Float | 47.74% |
Latest transcript on Divi's Laboratories Limited
1 day | +0.82% | ||
1 week | +3.67% | ||
Current month | +11.60% | ||
1 month | +13.39% | ||
3 months | +7.44% | ||
6 months | +11.66% | ||
Current year | -1.51% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 01-08-09 | |
Founder | 73 | 90-10-11 | |
Director of Finance/CFO | 74 | 94-11-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 73 | 90-10-11 | |
Chief Executive Officer | 46 | 01-08-09 | |
Director/Board Member | - | 14-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3,868 | +1.41% | 437 955 |
24-04-24 | 3,814 | +1.20% | 473,558 |
24-04-23 | 3,769 | +0.83% | 307,637 |
24-04-22 | 3,738 | +1.79% | 439,590 |
24-04-19 | 3,672 | -1.00% | 746,223 |
Delayed Quote NSE India S.E., April 25, 2024 at 02:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.51% | 12.15B | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- DIVISLAB Stock